Global Antidiabetics Trends in 2022
Antidiabetics is part of Therapy and includes a number of sub-sectors such as Insulin. You may also be interested in Anesthetics, Anti-Infective and Cardiovascular Drug.
Global diabetes medicine sales is projected to reach nearly $17 billion by 2026, according to a recent report. This is up 2% year on year from $15.4 billion in 2021. Since 2017, the global market has grown 7.9% year on year. Germany was the top country in global diabetes medicine sales in 2021, with $3.6 billion. Canada, Spain and Italy ranked numbers 2, 3 and 4 respectively. Iceland had a 16.4% year on year increase, while Greece was up 4.6% year on year since 2017. Global insulin exports are set to reach $8.4 billion by 2026, an increase of 0.6% year on year from $8.3 billion in 2021. Since 2016, global supply has grown 2.8% year on year. Germany was number 1 in insulin export in 2021, with $3.9 billion. France, Italy and China ranked numbers 2, 3 and 4 respectively. Singapore had an impressive 296.4% year on year increase, while Norway was down 78.4% year on year since 2016.
Top 10 countries
In 2022 major markets in the Antidiabetics Industry were:
Antidiabetics Market Data and Forecasts
How much the Antidiabetics industry is expected to grow to 2026?
More in Antidiabetics Industry for 2028Global Antidiabetics Statistics
- Insulin Import 183 countries (Asia, Africa, Latin America...)
- Pharmaceutical Imports 193 countries (Africa, Asia, Sub-Saharan Africa...)
- Insulin Export 108 countries (Asia, Europe, Middle East...)
- Pharmaceutical Exports 190 countries (Asia, Latin America, Africa...)
- Hormones Sales 48 countries (Europe, Northern Europe, Southern Europe...)
- Diabetes Medicine Sales 42 countries (Europe, Northern Europe, Southern Europe...)
- Herbicide Import 190 countries (Europe, Africa, Asia...)
- Medicine Use 130 countries (Europe, Northern Europe, Latin America...)
- Herbicide Export 152 countries (Europe, Eastern Europe, Southern Europe...)
- Herbicide Sales 57 countries (Europe, Southern Europe, Western Europe...)
Global Antidiabetics Industry Database
Improve your Knowledge with the latest Indicators and Trends
-
Insulin Market Trends: Unraveling Growth, Top Players, and Future Projections
The insulin sector is experiencing meaningful growth, driven primarily by the increasing prevalence of diabetes globally. The extensive research and development activities in the field of diabetes management have facilitated the advent of innovative insulin delivery systems which has spurred market growth. Moreover, significant enhancements in insulin formulations in terms...
Discover more insights -
Global Insulin Market: Comprehensive Insights into Size, Trends, and Impact Factors
The scope of the global insulin market is primarily driven by factors like the prevalence of diabetes, technological advancements in insulin delivery systems, and the rise of obesity. The growing diabetic population across the world necessitates increased insulin production, thereby inflating the market size. Moreover, advancements in technology are facilitating...
Discover more insights -
Deep-Dive into the Diverse Insulin Market: Key Products, Diabetes Types, and Segmentation Insights
The Insulin market is populated with an array of products categorized mainly into basal, rapid-acting, traditional, and premixed insulins. Basal and rapid-acting insulin products, such as insulin glargine and insulin lispro, maintain a dominant presence due to their critical role in diabetes management. Traditional human insulins, despite their lower cost,...
Discover more insights -
Neuroscience: A Comprehensive Analysis of Neuronal Acetylcholine Receptor Subunit Pipelines
Rapid advancement in understanding neuronal acetylcholine receptor subunits represents a significant base for evolution in neuroscience. The ability of these subunits to alter neurotransmission opens scope for treatment of neurological disorders. Additionally, their implication in various diseases and disorders has driven the market's investment in ongoing research. The targeted therapeutics...
Discover more insights -
Diabetes Therapeutics: Exploring Opportunities and Innovations in Treatment and Diagnosis
Currently, the market for diabetes therapies is ripe to a facet of aggressive competition due to an elevated prevalence of the disease across the globe. Standard treatments such as insulin and oral medications persist at the forefront of therapeutic strategies, although efforts to further refine and bolster their efficiency are...
Discover more insights